Find similar products:
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PLGB 41042/0050.
Skyrizi 180 mg and 360 mg solution for injection in cartridge
Skyrizi 180 mg solution for injection in cartridge
Skyrizi 360 mg solution for injection in cartridge
risankizumab
1. What Skyrizi is and what it is used for
2. What you need to know before you use Skyrizi
3. How to use Skyrizi
4. Possible side effects
5. How to store Skyrizi
6. Contents of the pack and other information
7. Instructions for use
Skyrizi contains the active substance risankizumab.
Skyrizi is used to treat patients 16 years and older with moderate to severe Crohn’s disease and adults with moderate to severe ulcerative colitis.
This medicine works by stopping a protein in the body called ‘IL-23’, which causes inflammation.
Crohn’s disease
Crohn’s disease is an inflammatory disease of the digestive tract. If you have active Crohn’s disease you will first be given other medicines. If these medicines do not work well enough, you will be given Skyrizi to treat your Crohn’s disease.
Ulcerative colitis
Ulcerative colitis is an inflammatory disease of the large bowel. If you have active ulcerative colitis you will first be given other medicines. If these medicines do not work well enough or if you cannot take these medicines, you will be given Skyrizi to treat your ulcerative colitis.
Skyrizi reduces the inflammation and can therefore help to reduce the signs and symptoms of your disease.
Talk to your doctor, pharmacist or nurse before and during the use of Skyrizi
It is important to keep a record of the batch number of your Skyrizi.
Every time you get a new pack of Skyrizi, note down the date and the batch number (which is on the packaging after “Lot”) and keep this information in a safe place.
Allergic reactions
Tell your doctor or seek medical help immediately if you notice any signs of an allergic reaction while you are taking Skyrizi such as
Skyrizi is not recommended for children and adolescents under 16 years of age. This is because Skyrizi has not been studied in this age group.
Tell your doctor, pharmacist or nurse
If you are not sure, talk to your doctor, pharmacist or nurse before and during the use of Skyrizi.
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine. This is because it is not known how this medicine will affect the baby.
If you are a woman who can become pregnant, you should use contraception while using this medicine and for at least 21 weeks after your last dose of Skyrizi.
If you are breast-feeding or are planning to breast-feed, talk to your doctor before using this medicine.
Skyrizi is not likely to affect your driving and use of machines.
This medicine contains less than 1 mmol sodium (23 mg) per cartridge, that is to say essentially ‘sodium-free’.
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
This medicine is given as an injection under your skin (called a ‘subcutaneous injection’).
You will begin treatment with Skyrizi with a starting dose which will be given by your doctor or nurse through a drip in your arm (intravenous infusion).
Starting doses
Crohn’s disease
How much?
When?
Ulcerative colitis
How much?
When?
Afterwards, you will receive Skyrizi as an injection under your skin.
Maintenance doses
Crohn’s disease
How much?
When?
Ulcerative colitis
How much?
When?
You and your doctor, pharmacist or nurse will decide if you should inject this medicine yourself. Do not inject yourself with this medicine unless you have been trained by your doctor, pharmacist or nurse. A caregiver may also give your injection after they have been trained.
Read section 7 ‘Instructions for use’ at the end of this leaflet before injecting Skyrizi yourself.
If you have used more Skyrizi than you should or the dose has been given sooner than prescribed, talk to your doctor.
If you forget to use Skyrizi, inject a dose as soon as you remember. Talk to your doctor if you are not sure what to do.
Do not stop using Skyrizi without talking to your doctor first. If you stop treatment, your symptoms may come back.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Talk to your doctor or get medical help immediately if you have symptoms of a serious infection such as
Your doctor will decide if you can keep using Skyrizi.
Tell your doctor, pharmacist or nurse if you get any of the following side effects
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system (see details below). By reporting side effects you can help provide more information on the safety of this medicine.
United Kingdom
or search for MHRA Yellow Card in the Google Play or Apple App Store.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the cartridge label and outer carton after ‘EXP’.
Store in a refrigerator (2°C - 8°C). Do not freeze.
If needed, you may also store the cartridge out of the refrigerator (up to a maximum of 25°C) for up to 24 hours.
Keep the cartridge in the original carton in order to protect from light.
Do not use this medicine if the liquid is cloudy or contains flakes or large particles.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is risankizumab.
Skyrizi 180 mg solution for injection in cartridge
Skyrizi 360 mg solution for injection in cartridge
Skyrizi is a clear and colourless to yellow liquid in a cartridge. The liquid may contain tiny white or clear particles.
Each pack contains 1 cartridge and 1 on-body injector.
This leaflet was last revised in 10/2024
To listen to or request a copy of this leaflet in Braille, large print or audio, please contact the Marketing Authorisation Holder.
Please read all of section 7 before using Skyrizi
Follow the steps below each time you use Skyrizi
Take the carton out of the refrigerator and leave it at room temperature, out of direct sunlight, for at least 45 up to 90 minutes before injecting.
Gather all supplies and wash your hands
Place the following items on a clean, flat surface
Wash and dry your hands.
Remove the white paper tray seal
Lift the plastic cover
Inspect the on-body injector
If the grey start button is pressed before placing it on your body, the on-body injector can no longer be used. If this happens, speak to your doctor, pharmacist or nurse.
Fully open the grey door
Put the on-body injector aside.
Inspect the cartridge
Carefully remove the cartridge from the plastic tray.
Check the cartridge
Clean the smaller bottom tip of the cartridge
Locate the smaller bottom tip of the cartridge
Load the cleaned cartridge into the on-body injector
Make sure to proceed to the next step without delay. Waiting will dry out the medicine.
Close the grey door
Swing the grey door to the left, then squeeze firmly and listen for the grey door to "snap" shut
Choose and clean your injection site
Choose from these 3 areas to inject:
Do not inject into areas of the skin that naturally fold or bulge because the on-body injector could fall off during wear.
Before the injection, wipe where you will inject in a circular motion with an alcohol pad.
Peel both tabs to expose skin adhesive
Turn the on-body injector over to find both green pull tabs
Peel away the large section using the green pull tab to expose the skin adhesive
Peel away the small section using the green pull tab to expose the skin adhesive. This will remove the clear plastic strip, activating the on-body injector
The Skyrizi on-body injector must be placed on the skin and injection must be started within 30 minutes after removing the green pull tabs or it will not work. Make sure to proceed to next step without delay.
If the status light flashes red, the on-body injector is not working properly. Do not continue to use it.
Speak to your doctor, pharmacist or nurse for assistance.
If the on-body injector is attached to your body, carefully remove it from your skin.
Prepare the on-body injector for placement
Make sure to place the on-body injector so that you can see the blue status light.
Place the on-body injector on your skin
Proceed without delay to the next step.
Start injection
Firmly press and release the grey start button
Do not continue to use the on-body injector if status light flashes red. Carefully remove from skin if the status light flashes red. If this happens, speak to your doctor, pharmacist or nurse.
Wait for the injection to finish
Do not continue to use the on-body injector if the status light flashes red. Carefully remove it from the skin if the status light flashes red. If this happens, speak to your doctor, pharmacist or nurse.
Injection is complete when
Remove the on-body injector
Proceed to the next step.
Check the on-body injector
Inspect the medicine window and status light.
Check to see that the white plunger fills the entire medicine window and the solid green light turns off, letting you know that all the medicine has been injected.
Disposal
Throw away the used on-body injector in a special disposal container straight after use.